Shares of Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report) traded up 7.9% during trading on Wednesday. The company traded as high as $8.43 and last traded at $8.43. 100 shares changed hands during trading, a decline of 96% from the average daily volume of 2,379 shares. The stock had previously closed at $7.8150.
Nxera Pharma Stock Performance
The company has a 50-day moving average of $7.38 and a 200-day moving average of $6.64.
Nxera Pharma Company Profile
Nxera Pharma Co, Ltd., formerly known as Sosei Group Corporation and Sosei Heptares, is a biopharmaceutical company focused on discovering and developing medicines that target G protein-coupled receptors (GPCRs). These receptors are involved in a wide range of biological processes and represent an important class of targets for treatments in areas including neuroscience, immunology, inflammation, metabolic disease and other therapeutic fields.
The company combines structure-based drug design, computational chemistry and its proprietary StaR technology to identify and optimize drug candidates.
Featured Stories
- Five stocks we like better than Nxera Pharma
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Nxera Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nxera Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
